PMID: 9584328May 19, 1998Paper

Cytochrome P450 specificity of metabolism and interactions of oxybutynin in human liver microsomes

Pharmacology & Toxicology
E LukkariO Pelkonen


Oxybutynin has an extensive first pass metabolism after oral administration, the main active metabolite being N-desethyloxybutynin. The purpose of this study was to investigate the CYP isoform specificity of oxybutynin N-deethylation and possible interactions. Oxybutynin N-deethylation in human liver microsomes in vitro was potently inhibited by ketoconazole (IC50 4.5 microM), less and variably by itraconazole and not by quinidine or several other reference inhibitors, suggesting that CYP3A enzymes are predominant catalysts of the reaction. Recombinant CYP3A5 enzyme had higher activity in oxybutynin N-deethylation than recombinant CYP3A4. Ketoconazole inhibited oxybutynin N-deethylation by the recombinant CYP3A4 and CYP3A5 almost completely, whereas itraconazole inhibited the activity of CYP3A4 more potently than that of CYP3A5. Oxybutynin inhibited CYP3A4- and CYP2D6- associated activities (testosterone 6 beta-hydroxylase and dextromethorphan O- demethylase, respectively) in human liver microsomes. CYP1A1/2-, CYP2A6-, CYP2C9- and CYP2E1-associated activities were inhibited less potently or not at all by oxybutynin when compared with reference inhibitors. Although the reasons for the weak and variable inhibition by itraconazole...Continue Reading


Apr 1, 1978·Analytical Biochemistry·A Aitio
Nov 1, 1990·Chemical Research in Toxicology·R PeterC S Yang
Jan 1, 1988·European Journal of Clinical Pharmacology·J DouchampsA Herchuelz
Jul 1, 1988·The Journal of Urology·J G OuslanderC L Yong
Aug 1, 1984·Acta Pharmacologica Et Toxicologica·L AaltonenR Sellman
Nov 15, 1980·Biochemical Pharmacology·O Pelkonen, J Puurunen
May 1, 1994·Clinical Pharmacology and Therapeutics·K T OlkkolaP J Neuvonen
Mar 1, 1994·British Journal of Clinical Pharmacology·J T BackmanP J Neuvonen
Oct 1, 1993·The American Journal of Medicine·J K Crane, H T Shih
Jan 1, 1993·European Journal of Clinical Pharmacology·S Pohjola-SintonenP Neuvonen
Mar 1, 1993·Clinical Pharmacology and Therapeutics·K T OlkkolaP J Neuvonen
Apr 1, 1996·Clinical Pharmacology and Therapeutics·A VarheP J Neuvonen
Jan 1, 1996·European Journal of Clinical Pharmacology·E LukkariP J Neuvonen

❮ Previous
Next ❯


Oct 6, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Martin C Michel, Sharath S Hegde
Oct 25, 2008·Current Urology Reports·Karl-Erik AnderssonRoberto Soler
Feb 22, 2011·European Journal of Drug Metabolism and Pharmacokinetics·Siamak Cyrus KhojastehAnthony Y H Lu
Aug 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·A D WoolfsonR J Gallagher
Apr 10, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Akimasa ShibukawIrving W Wainer
Nov 11, 2003·Clinical Pharmacokinetics·David R P Guay
May 9, 2002·Drug Metabolism Reviews·Slobodan Rendic
Apr 16, 2013·Revista da Associação Médica Brasileira·Nelson WoloskerPedro Puech-Leão
Dec 3, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Andrés Olivares-MoralesAmin Rostami-Hodjegan
Sep 13, 2003·Pharmacology & Toxicology·Jurandir Fernando ComarAdelar Bracht
Jul 19, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Takehito YamamotoTatsuji Iga
Apr 26, 2006·Basic & Clinical Pharmacology & Toxicology·Mette GillbergChristian Friis
Jun 1, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yoshiyuki ShirasakaA David Rodrigues
Apr 11, 2001·Therapeutic Drug Monitoring·J E Springate
Oct 26, 1999·The Annals of Pharmacotherapy·J M Ruscin, N E Morgenstern
Dec 21, 2006·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·H MizushimaH Ishizuka

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.